GLP-1 weight loss drugs insurance coverage is inconsistent: Medicare began a temporary program in July 2026 that lets eligible people with Part D pay $50 a month, while employer plans, marketplace plans and Medicaid may or may not cover these medicines, and many that do require prior authorization. Without coverage, cash prices from manufacturers have recently come down but are still often in the hundreds of dollars each month.
This article explains what is covered, what you may pay, and what to do if your plan says no. It is about coverage and cost, not a recommendation to take any medicine. Whether a GLP-1 is appropriate for you is a decision for you and your clinician.
Key Takeaways
- Medicare’s GLP-1 Bridge started July 1, 2026 and runs through December 31, 2027, with a flat $50 monthly copay for eligible Part D members.
- Eligibility under that program generally requires a BMI of 35 or higher, or a BMI of 27 or higher plus certain conditions such as heart disease or prediabetes.
- Employer and marketplace coverage for weight-loss use varies widely by plan and state. Check your formulary and exclusions.
- Self-pay prices have fallen, with many offers in the roughly $150 to $500 per month range depending on the product, dose and program.
- Compounded or unregulated copies carry safety concerns. Use FDA-approved products from licensed pharmacies.
What GLP-1 Weight Loss Drugs Are
GLP-1 receptor agonists mimic a gut hormone that affects appetite and blood sugar. The brand names most people recognize are Ozempic and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide, which also acts on a second hormone pathway). Wegovy and Zepbound are labeled for chronic weight management in adults with obesity, or with overweight plus a weight-related condition. Ozempic and Mounjaro are labeled for type 2 diabetes. Newer oral options have also reached the market.
That labeling distinction drives insurance coverage. Plans have long covered these drugs for diabetes, where they are routine, but have been more reluctant to cover them for weight loss alone. These are prescription medicines with real side effects, including nausea, diarrhea and, less often, gallbladder or pancreas problems. They are not appropriate for everyone, for example people with certain thyroid cancer histories or who are pregnant. Your prescriber should review your medical history and any medicines you take.
Coverage by Insurance Type
| Coverage source | Weight-loss coverage | What to expect |
|---|---|---|
| Medicare (Part D) | New temporary bridge program from July 2026 | $50 monthly copay for eligible members, clinical criteria apply |
| Employer plans | Optional, plan-by-plan | Some cover with prior authorization; others exclude weight-loss drugs |
| ACA marketplace plans | Varies by state benchmark and insurer | Check the formulary before you enroll |
| Medicaid | State decision | Some states cover, others do not |
| No coverage | Not applicable | Manufacturer self-pay programs or cash prices |
Medicare
Original Medicare has traditionally excluded drugs used for weight loss. Under the bridge program, which started July 1, 2026, Part D members who meet clinical criteria can get certain products for a flat $50 per month. Covered products named for the program include Wegovy (injection and pill), Zepbound and a newer oral medication. The copay does not change with the dose.
There are limits worth knowing. The $50 copay does not count toward your Part D deductible or the annual out-of-pocket cap, which is $2,100 in 2026. Low-income subsidy recipients cannot use that subsidy for these particular drugs. The program is temporary, and what happens after 2027 is unclear. Read how Part D prescription drug plans work for background on formularies and caps.
To use the program, your doctor must show you meet the criteria, and you should ask your pharmacy or plan how to enroll. Details can change, so confirm on Medicare.gov.
Employer plans
Employers decide whether to include weight-loss drugs, and many have restricted them because of cost. Where they are covered, expect prior authorization, a documented BMI, sometimes proof of a lifestyle program, and renewal checks. Some employers cover the drugs only for diabetes or for certain other conditions. Review your plan’s drug list or call member services, and ask HR whether coverage is planned to change at renewal.
Marketplace plans
ACA plans must cover prescription drugs as an essential benefit, but each state’s benchmark plan defines what is included, and weight-loss medicines are not guaranteed. When you shop, search the plan’s formulary for the exact drug, strength and tier, and read any notes on prior authorization or quantity limits. Open enrollment, which runs from November 1 on HealthCare.gov, is the best time to check, because you generally cannot change plans afterward without a qualifying life event.
Medicaid
Medicaid drug coverage is set by each state. Some states cover GLP-1s for obesity, and others have limited or ended coverage due to budgets. Federal announcements describe access to negotiated pricing for states that choose to take part, but participation is up to each state. Your state Medicaid office can tell you what applies.
What You Might Pay
List prices have been high, historically above $1,000 per month for injectables. Several developments changed what many people actually pay:
- Manufacturers launched direct-to-consumer cash programs, with self-pay offers that have ranged from about $149 to $499 per month depending on product and dose.
- A federal pricing arrangement with manufacturers announced that some products would be available at around $350 per month through a government cash-price site, with lower prices for the initial dose of oral versions.
- Medicare’s negotiated price of about $245 per month underlies the $50 copay program.
Prices change, and promotions can expire, so verify the current amount with the manufacturer’s website or your pharmacist. Self-pay purchases generally do not count toward your insurance deductible, although a few plans allow you to submit receipts, so ask.
Illustrative annual cost comparison
The figures below are examples, not quotes.
| Path | Monthly cost | 12-month cost |
|---|---|---|
| Medicare bridge copay | $50 | $600 |
| Employer plan with a $60 copay after approval | $60 | $720 |
| Cash price at $350 | $350 | $4,200 |
| Cash price at $499 | $499 | $5,988 |
The right row for you depends on your plan, and your total costs should include clinic visits, labs and any other medicines. If you pay cash, read how to lower prescription drug costs for general approaches such as comparing pharmacies and asking about assistance programs.
Why Insurers Say No (and What You Can Do)
Insurers commonly deny GLP-1 requests for these reasons:
- Plan exclusion. The plan does not cover drugs for weight loss at all. This usually cannot be appealed on clinical grounds, because it is a benefit design choice.
- Criteria not met. BMI below the threshold, missing weight-related condition, or no documented attempt at a lifestyle program.
- Missing paperwork. Prior authorization submitted without the right forms or chart notes.
- Step therapy. The plan wants you to try another medicine first.
- Quantity limits. Dosing or supply is limited to a certain amount per month.
If you are denied for a reason other than exclusion, ask your prescriber’s office to resubmit with supporting notes, then use the plan’s appeals process. Our guide on appealing a denied claim lays out the steps and timelines. You can also request a formulary exception, and your doctor can explain why a specific drug is medically necessary for you.
Be Careful With Shortcuts
High prices have created a market for compounded and unregulated versions sold online. The FDA has warned about unapproved or incorrectly dosed products, and compounded versions are not reviewed by the agency for safety and effectiveness the way approved drugs are. Dosing errors have been reported in some cases. Buy only through licensed pharmacies, require a valid prescription, and talk to your clinician before using any product you found online. Beware of websites that offer the drugs with no medical review.
It is also worth knowing that these medicines are meant to be used with other approaches, such as nutrition and physical activity, and that people often regain weight if they stop. That has coverage implications because plans may expect you to continue treatment long term, which affects cost planning. A clinician can talk with you about what long-term use might look like. For non-drug approaches, see our article on losing belly fat without crash dieting.
Questions to Bring to Your Prescriber
Coverage is only half the picture. A visit to a doctor or nurse practitioner is also where eligibility, safety and follow-up get decided, and the notes from that visit often determine whether prior authorization is approved. Consider asking:
- Is a GLP-1 medicine appropriate given my health history, other medicines and any plans for pregnancy?
- Which product is most likely to be covered by my plan, and does the dose schedule affect cost?
- What side effects should I watch for, and when should I call the office or seek urgent care, for example for severe, persistent abdominal pain?
- What labs or check-ins will I need, and are they covered?
- What is the plan if coverage ends or the price changes?
Keep copies of height, weight and BMI records, and any notes about related conditions, since insurers often ask for them.
How to Check Your Own Coverage
- Log in to your insurer’s portal and open the drug list (formulary). Search by brand name and generic name.
- Note the tier, any prior authorization, quantity limits and whether weight-loss use is excluded.
- Call member services and ask: “Is this covered for chronic weight management, not diabetes?” Write down the date, name and reference number.
- Ask your doctor’s office to submit prior authorization with BMI history and relevant conditions.
- If denied, request the denial in writing, ask for the specific criteria, and decide whether to appeal.
- If coverage is not available, compare manufacturer programs and pharmacy prices.
Frequently Asked Questions
Does insurance cover Ozempic for weight loss?
Ozempic is labeled for type 2 diabetes, and coverage is typically tied to that use. Wegovy contains the same active ingredient but is labeled for weight management, and plan rules differ.
Does Medicare cover weight loss drugs now?
Through a temporary bridge program that began July 1, 2026, eligible Part D members can pay $50 a month. It currently runs through December 31, 2027.
Who qualifies for the Medicare program?
Generally people with a BMI of 35 or higher, or a BMI of 27 or higher along with certain conditions such as heart disease or prediabetes. Your plan or doctor can confirm.
Why does my employer plan exclude these drugs?
Employers pay much of the cost, and many have chosen to limit coverage. Ask HR whether this might change at renewal.
Can I use a health savings account to pay?
Prescription drugs are generally eligible HSA expenses when prescribed by a clinician. Confirm eligibility with your plan administrator.
Are compounded versions a safe way to save money?
The FDA has raised safety concerns about unapproved and compounded copies. Talk to your doctor and use licensed pharmacies.
Will I need coverage forever?
Many people continue treatment long term, and stopping may lead to weight regain. Your clinician can discuss expectations.
Where can I find the latest details?
Medicare.gov for Medicare questions, your state Medicaid agency for Medicaid, and your insurer’s formulary for private plans.
Bottom Line
GLP-1 weight loss drugs insurance coverage depends on which plan you have, and the rules are changing quickly. Medicare’s $50 bridge program is the biggest recent shift, while private coverage remains a patchwork. Check your formulary, ask your prescriber to handle prior authorization, and consider cash programs only through licensed sources. Always make treatment decisions with your own clinician.
This article is for general informational purposes only and does not constitute medical, legal, or financial advice. Coverage rules, costs and guidelines change and vary by plan and state — consult a licensed healthcare professional or your insurer for guidance specific to your situation.
